92例支气管扩张患者病因学分析及与疾病严重程度的关系
[Abstract]:Background Bronchial dilation is a common terminal change of persistent pulmonary inflammation and repeated infections caused by different etiologies, that is, the irreversible expansion of the bronchi. Bronchiectasis is previously thought to be a rare disease, with a lack of large-scale epidemiological data and related studies, and is not sufficiently aware of the disease, and its morbidity, mortality and economic impact are likely to be underestimated. High resolution computed tomography (HRCT) is a non-invasive and high-sensitivity examination method. With the advancement of the medical level, HRCT is also becoming more and more popular, and the diagnosis of the bronchiectasis is also becoming more and more clear. The Association of the Chest of the United Kingdom, in 2010, released the latest guidelines for the non-cystic fibrosis of the bronchi, which classifies the causes of the bronchiectasis and recommends the treatment of patients with bronchiectasis. The causes of bronchiectasis are diverse and usually include the following categories: idiopathic, post-infection, bronchial mucociliary clearance dysfunction, primary immunodeficiency, secondary immune deficiency, autoimmune disease, allergic disease, and congenital development of the atmosphere, Bronchiolitis and others. The severity index (BSI) of the bronchiectasis is a classification system and a prediction tool for the severity of the bronchiectasis, including age, BMI, the percentage of forced expiratory volume in the first second (FEV1ppred%), and the previous 2-year hospitalization. In the past 1 year, the number of acute exacerbations, the grade of mMRC dyspnea, the condition of bacterial colonization, and the severity of radiological examination were 8 variables, and it was possible to comprehensively evaluate the severity of the disease from the multi-dimensional and comprehensive assessment of the severity of the disease. Bronchiectasis is a high-morbidity and high-mortality disease. If early diagnosis is carried out, the cause of the disease is determined, the severity of the disease is assessed, and different treatment schemes are provided, which can improve the quality of life of the patient and reduce the death rate. Objective To study the etiological spectrum of the patients with bronchiectasis and the relationship with the severity of the disease. Methods 92 patients with stable and stable bronchiectasis at the first affiliated hospital of Zhengzhou University were collected, and a comprehensive examination was conducted according to the guidance of the non-cystic fibrosis of the UK, and the medical history was inquired in detail, and the cause of the patient was determined. The severity of the patient's disease was assessed according to the BSI score. Results 1. General data:39 (42.4%) of the patients enrolled in the study,53 (57.6%) of women, mean age (52.7 to 14.7), and 47 (51.0%) in the 50 to 69-year-old group. The etiology of 92 cases of bronchiectasis included infection (41.3%), idiopathic bronchiectasis (23.9%), chronic obstructive pulmonary disease (COPD) (18.5%), asthma (10.8%), allergic bronchopulmonary aspergillosis, ABPA (2.2%), gastroesophageal reflux disease (GERD) (2.2%) and connective tissue disease (CTD) (1.1%), among which, tuberculosis was 52.6% after infection. There was no significant difference in the etiology of the patients with different sexes (P = 0.662). The severity of the disease was analyzed in 35 patients (38.0%), moderate in 13 (14.1%), and severe in 44 (47.8%). There was a significant difference in the cause of the patients with bronchiectasis (P0.05). The main diseases of the patients with mild and moderate bronchiectasis were idiopathic (mild 40.0%; moderate 38.4%) and after infection (mild 37.1%; moderate 23.1%); The major diseases in patients with severe bronchiectasis were due to post-infection (50.0%) and COPD (27.3%). With the increase of the severity of the disease, the HRCT score increased gradually (P0.05). Conclusion 1. Bronchiectasis, idiopathic bronchiectasis and COPD-associated bronchiectasis after infection are the most common cause of the bronchiectasis in adults. More than half of the post-infection bronchi are expanded to a tuberculosis infection. In mild and moderate patients, the bronchiectasis was common in the patients with idiopathic bronchiectasis and infection, and the bronchiectasis and the associated bronchiectasis in the patients with severe COPD were more common.
【学位授予单位】:郑州大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R562.22
【相似文献】
相关期刊论文 前10条
1 张锺儒,罗椒衍;每天1次量噻托铵治疗稳定的慢性阻塞性肺疾病可获长期支气管扩张[J];国外医学(内科学分册);2001年03期
2 段建明,安新,许芳,张大明;42例老年支气管扩张大咯血的治疗体会[J];中国煤炭工业医学杂志;2001年01期
3 张延泉;;支气管扩张[J];社区医学杂志;2006年04期
4 丁会;王建国;迟宝荣;;支气管哮喘与支气管扩张的关系[J];吉林大学学报(医学版);2006年03期
5 余毅;牛惠敏;;支气管动脉栓塞术治疗支气管扩张大咯血46例[J];中国煤炭工业医学杂志;2006年04期
6 卢树标;吕文慧;荣福;;支气管扩张病例应用23价肺炎球菌多糖疫苗的临床观察[J];海军医学杂志;2006年03期
7 张永标;张扣兴;;支气管扩张合并咯血的监护[J];新医学;2006年12期
8 蔡志容;;中西医结合治疗支气管扩张24例[J];现代医药卫生;2007年18期
9 王贵勤;;支气管扩张合并侵袭性肺曲霉菌病1例[J];中国临床保健杂志;2007年05期
10 马晓霞;李纪;;经纤维支气管镜注药治疗支气管扩张[J];中国医药导报;2008年14期
相关会议论文 前10条
1 丁会;迟宝荣;王建国;;支气管哮喘与支气管扩张的发病关系探讨[A];中华医学会第五次全国哮喘学术会议暨中国哮喘联盟第一次大会论文汇编[C];2006年
2 谭春婷;贺正一;刘颖;辛小燕;焦蕴敏;刘晓霞;;不同类型支气管扩张的比较研究[A];中华医学会第七次全国呼吸病学术会议暨学习班论文汇编[C];2006年
3 崔愈;;支气管扩张的护理体会[A];全国民政医学护理专业第三次学术会议论文汇编[C];2001年
4 谭晖;;中西医结合治疗支气管扩张40例[A];全国首届侗医药学术研讨会论文专辑[C];2004年
5 张跃海;;支气管扩张所致大咯血的介入治疗[A];2008年浙江省放射学年会论文汇编[C];2008年
6 杨达伟;宋元林;白春学;;支气管扩张合并囊性纤维化患者的临床回顾性研究[A];中华医学会呼吸病学年会——2011(第十二次全国呼吸病学学术会议)论文汇编[C];2011年
7 郭永庆;葛炳生;刘德若;石彬;田燕雏;李福田;宋之乙;;支气管剔除治疗支气管扩张[A];中华医学会第六次全国胸心血管外科学术会议论文集(胸外科分册)[C];2006年
8 陈卫强;薛庆亮;李继东;刘卫;;经纤维支气管镜治疗支气管扩张并感染临床观察[A];中华医学会呼吸病学年会——2013第十四次全国呼吸病学学术会议论文汇编[C];2013年
9 田欣伦;吴翔;徐凯峰;朱元珏;;支气管扩张患者的病因及临床特点分析[A];中华医学会呼吸病学年会——2013第十四次全国呼吸病学学术会议论文汇编[C];2013年
10 侯登华;郭玉林;蔡磊;杜玉秀;严冰;赵俊玲;袁志红;李云香;;超选择性支气管动脉介入栓塞术治疗支气管扩张引起的咯血附8例报告[A];第六届西部介入放射学术会议宁夏医学会放射学分会第四届年会介入放射学新技术继续教育学习班论文汇编[C];2009年
相关重要报纸文章 前10条
1 本报特约记者 俞忠良;支气管扩张能治好吗?[N];健康时报;2003年
2 北京中国中医研究院西苑医院呼吸科主任 张燕萍;支气管扩张能否根治[N];家庭医生报;2004年
3 时毓民;支气管扩张也会殃及儿童[N];家庭医生报;2008年
4 本报记者罗辉;支气管扩张能治好吗?[N];健康时报;2003年
5 呼吸内科专家历风光接听热线整理;患了支气管扩张该怎么办[N];家庭医生报;2004年
6 刘德若;支气管扩张术后为何还咯痰[N];健康报;2007年
7 时毓民;儿童也会有支气管扩张[N];家庭医生报;2008年
8 ;支气管扩张的防治原则[N];人民日报海外版;2001年
9 主任医师 于伟华;肺部感染后遗症怎么治疗[N];卫生与生活报;2006年
10 高静;治支气管扩张药膳[N];医药养生保健报;2008年
相关博士学位论文 前2条
1 樊长征;补中柴前连梅煎减少支气管扩张患者急性加重次数的临床疗效研究[D];中国中医科学院;2016年
2 李佳成;马凡综合征和支气管扩张致病突变研究[D];北京协和医学院;2017年
相关硕士学位论文 前10条
1 赵亚楠;多层螺旋CT提示支气管扩张原因的价值研究[D];山西医科大学;2014年
2 赵京梅;慢性阻塞性肺疾病与支气管扩张并存的相关因素研究[D];河北医科大学;2015年
3 宋燕峰;支气管扩张患者病原菌现状及耐药性分析[D];天津医科大学;2015年
4 叶宁;支气管扩张患者的肺功能改变及易于合并COPD的高危因素的探究[D];吉林大学;2016年
5 刘娇;182例重庆地区支气管扩张儿童临床特征及多中心病因构成分析[D];重庆医科大学;2016年
6 王正;慢性阻塞性肺疾病合并/未合并支气管扩张患者的CRP、PCT等炎症指标的比较[D];河北医科大学;2016年
7 蒲晓新;支气管扩张的诊治现状[D];吉林大学;2015年
8 刘振刚;沙美特罗替卡松治疗支气管扩张并不可逆气流受限患者的疗效与安全性研究[D];山东大学;2012年
9 林琳;寇辉教授治疗支气管扩张临床经验浅谈[D];辽宁中医药大学;2011年
10 樊萍;支气管扩张病人痰分支杆菌检出率探讨[D];暨南大学;2003年
,本文编号:2487169
本文链接:https://www.wllwen.com/yixuelunwen/huxijib/2487169.html